Acute Basophilic Leukemia

This is a specific type of acute leukemia where the cancer cells are mostly immature basophils, a type of white blood cell. It's a rare form of leukemia.

Condition

What people with Acute Basophilic Leukemia report

Every report comes from a Lived member, sent anonymously.

Have you had Chemotherapy infusion for Acute Basophilic Leukemia?

NameHow it went

About Acute Basophilic Leukemia

What It Is

Acute basophilic leukemia is a rare, fast-growing blood cancer. It is a subtype of acute myeloid leukemia (AML), the group of leukemias that start in the bone marrow cells that normally become certain white blood cells, red blood cells and platelets. In this subtype, the leukemia cells mostly develop toward basophils, a kind of white blood cell that carries granules of histamine and is involved in allergic reactions. It accounts for fewer than 1 in 100 AML cases. Like other acute leukemias, it crowds out the healthy cells the marrow should be making. That causes the main problems people notice: tiredness and breathlessness from anemia, infections, and easy bruising or bleeding. What sets this subtype apart is histamine released from the leukemic basophils. It can cause itching and hives, nausea, diarrhea, indigestion or stomach ulcers, and in some people low blood pressure. Some people also have an enlarged liver or spleen, skin involvement, or areas of bone damage.

Causes & Risk Factors

In most people no cause is found. As with other forms of AML, the disease begins with acquired changes in the genetic material of a bone marrow cell. These changes happen during a person's life; they are not usually inherited and are not caused by anything the person did. Some cases arise on their own. Others develop from an existing bone marrow disorder, most often chronic myeloid leukemia (CML) as it progresses, and rarely from myelodysplastic syndrome, a condition in which the marrow makes faulty blood cells. Previous chemotherapy or radiation therapy is a recognized risk factor for AML in general. The disease has been reported across a wide range of ages.

How It's Diagnosed

Diagnosis usually starts with a complete blood count and a look at the blood under a microscope, which may show low counts and immature cells. Because the leukemia lives in the marrow, a bone marrow aspiration and biopsy are needed: a sample of liquid marrow and a small piece of bone are removed for testing. The key finding is a large share of immature cells (blasts) together with many basophil-type cells, which proposed criteria set at 20% or more blasts and 40% or more basophils. Ordinary stains often do not identify these cells clearly, so specialists use flow cytometry, a test that reads markers on the surface of each cell, to confirm they belong to the basophil line rather than to mast cells or other myeloid cells. Genetic tests on the marrow are just as important. They look for the Philadelphia chromosome (BCR-ABL1), which would point to CML rather than primary basophilic leukemia, and for other changes that place the disease in a different AML group. Ruling out these look-alikes, and ruling out a harmless rise in basophils from another cause, changes how the disease is treated.

Treatment Options

There is no standard treatment designed for acute basophilic leukemia. Because it is so rare, no clinical trials have focused on it, and care follows the approach used for other high-risk forms of AML, guided by a leukemia specialist. For people healthy enough for intensive treatment, this usually means strong combination chemotherapy in the hospital to try to clear the leukemia from the marrow (induction), followed by further treatment to keep it away. An allogeneic stem cell transplant, which replaces the bone marrow with cells from a matched donor, is often considered for people who reach remission, since it offers the best chance of longer-term control but carries serious risks of its own. For older people or those who cannot tolerate intensive chemotherapy, lower-intensity options are used, such as azacitidine or decitabine (drugs that alter how leukemia cells read their genes), sometimes combined with venetoclax, a pill that helps trigger leukemia cell death. Responses in reported cases are often short, and the disease frequently resists treatment, so clinical trials are worth asking about. Supportive care runs alongside all of this, including transfusions, treatment of infections and relief of histamine-related symptoms such as itching.

What to Expect

Acute basophilic leukemia usually moves quickly, and the reported outlook is generally poor. Many people described in published reports lived less than a year, although those reports are a small number of cases and individual courses vary, especially for people who reach remission and go on to a transplant. Treatment is demanding. Intensive chemotherapy usually means a hospital stay during the first phase, with frequent blood tests, transfusions and a high risk of infection while counts are low. Lower-intensity treatment is often given in monthly cycles, mostly as an outpatient, but still needs close monitoring. Repeated bone marrow tests show whether the leukemia is responding. Because the course can be short and uncertain, many people find it helpful to discuss goals of care early, including what matters most to them and how palliative care can help with symptoms alongside or in place of leukemia treatment.

When to Seek Help

See a doctor soon for ongoing tiredness, unexplained bruising, frequent infections, or persistent itching and hives without a clear cause, especially if a blood test has shown abnormal counts or high basophils. During treatment, call your care team right away for a fever of 100.5°F (38°C) or higher, chills or other signs of infection, since infection with low white counts can become life threatening quickly. Call them promptly as well for bleeding that is hard to stop, new bruising or tiny red spots on the skin, or dizziness or faintness that could reflect low blood pressure.

Questions to Ask Your Doctor

  1. 1.Which tests confirmed that this is acute basophilic leukemia rather than CML or another type of AML?
  2. 2.Am I a candidate for intensive chemotherapy and a stem cell transplant, and what would each involve?
  3. 3.Are there clinical trials I could join for this rare leukemia?
  4. 4.What do my genetic test results mean for treatment and outlook?
  5. 5.How can palliative care help with symptoms like itching or stomach problems while I'm being treated?

Last reviewed • Oct 2026

Educational content, not medical advice.